发明公开
EP2773335A1 NEPRILYSIN INHIBITORS
有权
OXALSÄUREAMIDEALS NEPRILYSIN INHIBITOREN,DEREN PHARMAZEUTISCHE ZUSAMMENSETZUNG UND DEREN HERSTELLUNGSVERFAHREN
- 专利标题: NEPRILYSIN INHIBITORS
- 专利标题(中): OXALSÄUREAMIDEALS NEPRILYSIN INHIBITOREN,DEREN PHARMAZEUTISCHE ZUSAMMENSETZUNG UND DEREN HERSTELLUNGSVERFAHREN
-
申请号: EP12783830.8申请日: 2012-11-01
-
公开(公告)号: EP2773335A1公开(公告)日: 2014-09-10
- 发明人: HUGHES, Adam , FENSTER, Erik , FLEURY, Melissa , GENDRON, Roland , MORAN, Edmund, J.
- 申请人: Theravance, Inc.
- 申请人地址: 901 Gateway Boulevard South San Francisco, CA 94080 US
- 专利权人: Theravance, Inc.
- 当前专利权人: Theravance, Inc.
- 当前专利权人地址: 901 Gateway Boulevard South San Francisco, CA 94080 US
- 代理机构: Scott, Susan Margaret
- 优先权: US201161554625P 20111102
- 国际公布: WO2013067163 20130510
- 主分类号: A61K31/165
- IPC分类号: A61K31/165 ; A61K31/215 ; C07C231/02 ; C07C233/56 ; C07C241/04 ; C07C243/30 ; C07C271/22 ; C07C317/40 ; A61P5/00 ; A61P9/00
摘要:
where R1-R6, a, b, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.
公开/授权文献
信息查询